Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Return on Equity [ROE] (2014 - 2018)

Updated

Altamira Therapeutics' Return on Equity [ROE] came in at -137.22% for FY2019, up 1433.85 percentage points from -1571.07% in FY2018.

Analysis

Altamira Therapeutics (CYTOF) Return on Equity [ROE] (2014 - 2018) Analysis & Trends

  • Per Business Quant, earlier years put Return on Equity [ROE] at -1571.07% in FY2018 (-1163.38 pp) and -407.69% in FY2017.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -793.16%
Dec 31, 2017 -51.06%
Sep 30, 2017 -49.02%
Jun 30, 2017 -341.00%
Mar 31, 2017 -251.22%
Dec 31, 2016 -184.61%
Sep 30, 2016 -131.21%
Jun 30, 2016 -88.19%
Mar 31, 2016 -47.81%
Dec 31, 2015 -42.46%
Sep 30, 2015 -53.38%
Jun 30, 2015 -52.55%
Mar 31, 2015 -30.91%
Dec 31, 2014 -25.64%
Sep 30, 2014 -53.42%
API Access

Altamira Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYTOF&period=max&api_key=YOUR_API_KEY